Is there an association between hyposmia and respiratory dysfunction in first degree relatives of Parkinson‘s disease patients? Source: Annual Congress 2010 - Respiratory muscles and breathing: assessment and training Year: 2010
Rate of progression of lung function impairment in α1-antitrypsin deficiency Source: Eur Respir J 2009; 33: 1338-1344 Year: 2009
Inspiratory muscle dysfunction relates to clinical disease severity in patients with type I myotonic dystrophy Source: International Congress 2019 – Lung function and respiratory muscle testing Year: 2019
Relationship between lung function disorders and condition of cardiovascular system in patients with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 422s Year: 2003
Distribution of severity of patients with obstructive lung disease in an at risk population Source: Eur Respir J 2004; 24: Suppl. 48, 474s Year: 2004
Relationship between lung function impairment and incidence or recurrence of cardiovascular disease in a middle-aged cohort Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD Year: 2007
Evaluation of metabolic profile in patients with chronic obstructive pulmonary disease and correlation between the metabolic parameters and the severity of disease Source: Eur Respir J 2006; 28: Suppl. 50, 625s Year: 2006
Cardio-vascular co-morbidities and severity of lung function impairment in a COPD cohort Source: Eur Respir J 2006; 28: Suppl. 50, 160s Year: 2006
Clinical characteristics and disease severity of adults with cystic fibrosis with at least one residual function mutation Source: International Congress 2018 – Cystic fibrosis in adults: current research Year: 2018
Systemic effects in patients with chronic obstructive pulmonary disease: a role of disease duration and disease severity Source: Annual Congress 2009 - Prognosis and comorbidities in COPD Year: 2009
Two patients with the same type of iatrogenic disease Source: Eur Respir J 2005; 25: 389-391 Year: 2005
Frequency and features of formation of chronic kidney disease (CKD) in patients with chronic obstructive pulmonary disease. Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019
Impact of pulmonary function on cardiovascular disease events in persons with metabolic syndrome and diabetes Source: Annual Congress 2011 - Comorbidities and impact on society of asthma and COPD Year: 2011
Relationship between quality of life, exercise capacity and disease severity in patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - Clinical parameters in airway diseases Year: 2011
Relationship between quality of life, exercise capacity and disease severity in patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - What do individuals know about their disease? Educational needs, the psychological impact of chronic respiratory disease and health-related quality of life Year: 2011
Comparison of pulmonary functions and quality of life in patients with parkinson’s disease and multiple system atrophy Source: Virtual Congress 2020 – Tapas of respiratory physiotherapy Year: 2020
Analysis of parameters of lung function in patients with severe chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 214s Year: 2001
Prevalence, correlates and mortality impact of chronic obstructive pulmonary disease in end stage kidney disease Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects Year: 2008
Bacterial burden in the lower airways predicts disease progression in idiopathic pulmonary fibrosis and is independent of radiological disease extent Source: Eur Respir J, 55 (4) 1901519; 10.1183/13993003.01519-2019 Year: 2020
Functional status in patients with chronic lung disease Source: Eur Respir J 2007; 30: Suppl. 51, 652s Year: 2007